1. Home
  2. ONCO vs AMBO Comparison

ONCO vs AMBO Comparison

Compare ONCO & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCO
  • AMBO
  • Stock Information
  • Founded
  • ONCO 2018
  • AMBO 2000
  • Country
  • ONCO United States
  • AMBO United States
  • Employees
  • ONCO N/A
  • AMBO N/A
  • Industry
  • ONCO Biotechnology: Pharmaceutical Preparations
  • AMBO Other Consumer Services
  • Sector
  • ONCO Health Care
  • AMBO Real Estate
  • Exchange
  • ONCO Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • ONCO 1.8M
  • AMBO 8.8M
  • IPO Year
  • ONCO 2022
  • AMBO 2010
  • Fundamental
  • Price
  • ONCO $4.77
  • AMBO $2.59
  • Analyst Decision
  • ONCO
  • AMBO
  • Analyst Count
  • ONCO 0
  • AMBO 0
  • Target Price
  • ONCO N/A
  • AMBO N/A
  • AVG Volume (30 Days)
  • ONCO 226.4K
  • AMBO 6.7K
  • Earning Date
  • ONCO 06-12-2025
  • AMBO 01-01-0001
  • Dividend Yield
  • ONCO N/A
  • AMBO N/A
  • EPS Growth
  • ONCO N/A
  • AMBO N/A
  • EPS
  • ONCO N/A
  • AMBO 0.11
  • Revenue
  • ONCO $1,925,313.00
  • AMBO $9,392,000.00
  • Revenue This Year
  • ONCO N/A
  • AMBO N/A
  • Revenue Next Year
  • ONCO N/A
  • AMBO N/A
  • P/E Ratio
  • ONCO N/A
  • AMBO $23.33
  • Revenue Growth
  • ONCO 153.70
  • AMBO 2.50
  • 52 Week Low
  • ONCO $3.82
  • AMBO $1.00
  • 52 Week High
  • ONCO $1,190.00
  • AMBO $5.55
  • Technical
  • Relative Strength Index (RSI)
  • ONCO 43.03
  • AMBO 44.84
  • Support Level
  • ONCO $3.92
  • AMBO $2.20
  • Resistance Level
  • ONCO $5.10
  • AMBO $2.82
  • Average True Range (ATR)
  • ONCO 0.75
  • AMBO 0.19
  • MACD
  • ONCO 0.03
  • AMBO -0.01
  • Stochastic Oscillator
  • ONCO 24.80
  • AMBO 54.44

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

Share on Social Networks: